CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $28.12 ($84,360)
- 4 Open-market sale Director sold 5,000 shares at $31.93 ($159,642)
- 4 Open-market sale Director sold 16,181 shares at $30.00 ($485,466)
- 4 Open-market sale Chief Medical Officer sold 16,160 shares at $30.00 ($484,800)
- 4 Open-market sale Chief Financial Officer sold 33,000 shares at an average $29.99 ($989,694)
- 4 Open-market sale President and CEO sold 19,578 shares at $29.43 ($576,141)
- 4 Open-market sale Chief Medical Officer sold 23,840 shares at $30.00 ($715,200)
- 4 Open-market sale Director sold 3,819 shares at $30.00 ($114,570)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Chief Financial Officer sold 2,548 shares at $26.69 ($68,010)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 6,526 shares at $25.01 ($163,215)
- 4 Open-market sale Director sold 10,000 shares at $25.01 ($250,078)
- 4 Open-market sale President and CEO sold 13,052 shares at $21.04 ($274,614)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $21.11 ($52,775)
- 4 Open-market sale Director sold 5,000 shares at $22.29 ($111,426)
- 4 Exercise or conversion Chief Medical Officer acquired 15,117 shares (option exercise)
Page 13 of 20 · 400 filings